Support teaching, research, and patient care.
Richard Mainwaring, MD, has been a pediatric cardiac surgeon since 1990 and has been a faculty member at the Stanford University School of Medicine since 2003.During Dr. Mainwaring’s career as a surgeon, he has contributed to this specialized field of surgery in many realms, including clinical medicine, basic science research, and publications. Dr. Mainwaring is a member of all four professional thoracic surgical organizations, including the American Association of Thoracic Surgery, Society for Thoracic Surgeons, Western Thoracic Surgical Association, and the Southern Thoracic Surgical Association and is also a member of the American College of Surgeons and Congenital Heart Surgeons' Society.In 2012, the congenital cardiac surgery fellowship program at Lucile Packard Children’s Hospital (LPCH) received accreditation from the Accreditation Council for Graduate Medical Education (ACGME). This program is one of thirteen accredited congenital cardiac surgery training programs in the US. Dr. Mainwaring has been named the program director for this program and was recently invited to join the Thoracic Surgical Directors Association. Dr. Mainwaring teaches intra-operative management and surgical technique to the congenital cardiac surgery fellows. Our current fellow is Louis Capecci, MD.The congenital cardiac surgery fellowship program has had seven graduates to date, including: Ashok Muralidaran, MD (now at OHSU Healthcare, Portland, OR) Sergio Carrillo, MD (now at Nationwide Children's, Columbus, OH) Sameh Said, MD (now at the Mayo Clinic, Rochester, MN)Ali Ibrahimiye, MD (now at Children's Hospital & Medical Center, Omaha, NE). Michael Ma, MD (now at the Stanford School of Medicine)Lou Capecci, MD (2021-2022, now a member of the Stanford faculty and runs the program at Kapi’olani Medical Center for Women and Children in Hawaii)Mac Felmly, MD (2021-2022, now a Clinical Instructor at Stanford)
Professional Interests: Pediatric cardiovascular surgery, surgery for adults with congenital heart disease
Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine
(Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease
during cardiopulmonary bypass surgery. Funding Source - FDA OOPD.
View full details